000 | 01315 a2200337 4500 | ||
---|---|---|---|
005 | 20250516161726.0 | ||
264 | 0 | _c20140317 | |
008 | 201403s 0 0 eng d | ||
022 | _a1531-703X | ||
024 | 7 |
_a10.1097/CCO.0b013e328363df0b _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFerrero, Simone | |
245 | 0 | 0 |
_aThe current therapeutic scenario for relapsed mantle cell lymphoma. _h[electronic resource] |
260 |
_bCurrent opinion in oncology _cSep 2013 |
||
300 |
_a452-62 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAlgorithms |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
650 | 0 | 4 |
_aLymphoma, Mantle-Cell _xtherapy |
650 | 0 | 4 |
_aMolecular Targeted Therapy _xmethods |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aRecurrence |
700 | 1 | _aDreyling, Martin | |
773 | 0 |
_tCurrent opinion in oncology _gvol. 25 _gno. 5 _gp. 452-62 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/CCO.0b013e328363df0b _zAvailable from publisher's website |
999 |
_c22934800 _d22934800 |